(CIDRAP News) – Influenza activity continued its sharp rise through the last week of 2012, the Centers for Disease Control and Prevention (CDC) said today.
"Reports of influenza-like-illness (ILI) are nearing what have been peak levels during moderately severe seasons," said Joe Bresee, MD, chief of epidemiology and prevention in the CDC's flu division, in a CDC statement today.
(CIDRAP News) – Flu activity in the United States, Canada, and parts of Europe continues to increase, but for the most part, levels of both mild and severe illness are low compared with past flu seasons, the World Health Organization (WHO) said today.
Activity appears to have peaked in a few Northern Hemisphere locations, such as some countries in Western Europe, North Africa, and northern China, according to the WHO.
(CIDRAP News) Flu activity remained low in the Northern Hemisphere last week, with only a few countries, such as Costa Rica and Cameroon, reporting spikes in the number of cases, the World Health Organization (WHO) said today.
Costa Rica is the only tropical country in the Americas to report increasing numbers of cases, which are primarily influenza A/H3N2, the WHO said.
(CIDRAP News) Flu activity is increasing in many of the Northern Hemisphere's temperate-zone countries, with influenza B cocirculating with the 2009 pandemic H1N1 virus across Europe and teaming up with influenza A (H3N2) in the United States and Canada, the World Health Organization (WHO) said in its latest update.
(CIDRAP News) European health officials today reported signs of an increasing rate of resistance to oseltamivir (Tamiflu) in Europe's predominant subtype of influenza virus, but they cautioned that the rate seen in isolates tested so far may not reflect the real situation.
(CIDRAP News) European officials yesterday reported more evidence that one of the three types of seasonal influenza viruses is showing resistance to oseltamivir (Tamiflu) and said this represents the first clear sign that the resistant variant can spread.
(CIDRAP News) An early report on the seasonal influenza strains circulating in Europe reveals that some H1N1 viruses show signs of resistance to the antiviral drug oseltamivir, the European Centre for Disease Prevention and Control (ECDC) reported this week.